Product NDC: | 52125-011 |
Proprietary Name: | SELZENTRY |
Non Proprietary Name: | maraviroc |
Active Ingredient(s): | 150 mg/1 & nbsp; maraviroc |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52125-011 |
Labeler Name: | REMEDYREPACK INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022128 |
Marketing Category: | NDA |
Start Marketing Date: | 20130218 |
Package NDC: | 52125-011-02 |
Package Description: | 30 TABLET, FILM COATED in 1 BLISTER PACK (52125-011-02) |
NDC Code | 52125-011-02 |
Proprietary Name | SELZENTRY |
Package Description | 30 TABLET, FILM COATED in 1 BLISTER PACK (52125-011-02) |
Product NDC | 52125-011 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | maraviroc |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20130218 |
Marketing Category Name | NDA |
Labeler Name | REMEDYREPACK INC. |
Substance Name | MARAVIROC |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | CCR5 Co-receptor Antagonist [EPC],Chemokine Co-receptor 5 Antagonists [MoA] |